Original language | English |
---|---|
Number of pages | 2 |
Journal | Journal of Clinical Oncology |
Volume | 34 |
Issue number | 15 |
DOIs | |
Publication status | Published - 20 May 2016 |
Event | 52nd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States Duration: 3 Jun 2016 → 7 Jun 2016 |
A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors
Jayesh Desai, Ben Markman, Shahneen Kaur Sandhu, Hui Kong Gan, Michael Friedlander, Ben Tran, Tarek Meniawy, Vishal Boolell, Duncan Colyer, Christie Norris, Malaka Ameratunga, Jason Yang, Kang Li, Lai Wang, Lusong Luo, Zhen Qin, Michael Millward
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
2
Citations
(Web of Science)